Past Speakers

Titles and organizational affiliations are reflective of the time of the previous Summit and may have since changed.

  • FRANCIS COLLINS, MD, PhD

    Acting Science Advisor to the President of the United States

  • CARLOS BUSTAMONTE, PhD

    Founder & CEO
    Galatea Bio, Inc.

  • TRENT HAYWOOD, MD, JD

    SVP & Chief Medical Officer
    Blue Cross Blue Shield Association

  • MARA ASPINALL

    Managing Director & Co-founder
    BlueStone Venture Partners

  • DEE ANNA SMITH

    CEO
    Sarah Cannon

  • ROB METCALF

    CEO
    Concert Genetics

  • LISA ALDERSON

    Founder & CEO
    Genome Medical

  • BEN SOLOMON, MD

    Clinical Director, NHGRI
    National Institutes of Health (NIH)

  • MIRA IRONS, MD

    Chief Health & Science Officer
    American Medical Association (AMA)

  • JAMES LU, MD, PHD

    Co-founder & CEO
    Helix

  • ELLEN MATLOFF, MS, CGC

    Co-founder & CEO
    MyGeneCounsel

  • ELI CASDIN

    Chief Investment Officer
    Casdin Capital

  • TAHA KASS-HOUT, MD, MS

    Chief Health Informatics Officer
    FDA

  • JILL HAGENKORD, MD

    Chief Medical Officer
    Optum Genomics

  • PHIL FEBBO, MD

    Chief Medical Officer
    Illumina

  • GILLIAN HOOKER, PHD, SCM, CGC

    Chief Scientific Officer
    Concert Genetics

  • BOB NUSSBAUM, MD

    Chief Medical Officer
    Invitae

  • DAWN BARRY

    President & Co-founder
    LunaDNA

  • KATE DONIGAN, PHD

    Director, Personalized Medicine and Molecular Genetics | Deputy Office Director (acting), CDRH/OIR
    FDA

  • MATT MIGHT, PHD

    Director, Hugh Kaul Precision Medicine Institute
    University of Alabama Birmingham

  • SHUVAYU SEN, PHD

    Executive Director, Center for Observational & Real-World Evidence
    Merck

  • TRISH BROWN, MS, CGC

    Genomics and Precision Medicine Program Director
    Aetna

  • NICK NACLERIO

    Founding Partner
    Illumina Ventures

  • DEVEN MCGRAW

    Lead, Data Stewardship & Data Sharing
    Invitae

  • CALEB BUPP, MD

    Division Chief, Medical Genetics and Genomics
    Spectrum Health and Helen DeVos Children’s Hospital

  • BRYCE OLSON

    Global Marketing Director, Health & Life Sciences
    Intel

  • LON CASTLE, MD

    Associate CMO, Precision Medicine Service
    eviCore

  • JESSICA ZEASKE, PHD

    Partner
    Echo Health Ventures

  • VINCENT NELSON, MD, MPH

    SVP & Deputy Chief Medical Officer
    Centene

  • CHRISTY MOORE, MS, CGC

    Genetics Program Manager
    Blue Shield of California

  • JOHN FOX, MD, MHA

    Senior Medical Director, Americas, Market Access
    Illumina

  • MATT NELSON, PHD

    VP, Genetics & Genomics
    Deerfield Discovery & Development

  • SUZANNE BELINSON, PHD

    VP, Commercial Markets
    Tempus

  • PRISCILLA ALFARO, MD

    VP, Payment Integrity
    Blue Cross Blue Shield of North Carolina

  • PETER DEVAULT

    VP, Genomics & Interoperability
    Epic

  • STEVE GOLDBERG, MD

    VP, Chief Health Officer, Medical Affairs & Diagnostic Services
    Quest Diagnostics

  • BEN PARK, MD, PHD

    Director, Vanderbilt-Ingram Cancer Center & Professor of Medicine (Hematology / Oncology)
    Vanderbilt University Medical Center

  • CRAIG HUNTER

    Vice President & General Manager Oncology, Genetics, and Laboratory Medicine
    Carelon

  • HOLLI DILKS, PHD

    Global Head of Field Medical, Medical Affairs
    Foundation Medicine

  • JIM JIRJIS, MD

    VP, Chief Health Information Officer
    HCA Healthcare

  • HOWARD LEVY, MD, PHD

    Associate Professor of Medicine
    Johns Hopkins Medical Center

  • JULIE EGGINGTON, MS, PHD

    Co-founder & CEO
    Center for Genomic Interpretation

  • DAX KURBEGOV, MD

    VP & Physician-in-Chief of Clinical Programs
    Sarah Cannon

  • KATHERYN LANG, MD

    Global Medical Strategy Head of Data Science
    Pfizer